Mediantechn (ALMDT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mediantechn (ALMDT) has a cash flow conversion efficiency ratio of 0.301x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-10.57 Million ≈ $-12.36 Million USD) by net assets (€-35.15 Million ≈ $-41.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Mediantechn (ALMDT) market capitalisation for the company's overall valuation and market capitalisation.
Mediantechn - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Mediantechn's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Mediantechn Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mediantechn ranked by their cash flow conversion efficiency. See ALMDT operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The ONE Enterprise Public Company Limited
BK:ONEE-R
|
N/A |
|
Spandana Sphoorty Financial Limited
NSE:SPANDANA
|
0.597x |
|
Expensify Inc
NASDAQ:EXFY
|
0.063x |
|
Value Added Technology Co. Ltd
KQ:043150
|
0.022x |
|
Garuda Construction & Engineering
NSE:GARUDA
|
0.011x |
|
CJ Freshway Corporation
KQ:051500
|
0.071x |
|
Singer Thailand Public Company Limited
BK:SINGER-R
|
0.006x |
|
Exacompta Clairefontaine
PA:ALEXA
|
0.200x |
Annual Cash Flow Conversion Efficiency for Mediantechn (2013–2025)
The table below shows the annual cash flow conversion efficiency of Mediantechn from 2013 to 2025. View today's stock price for Mediantechn for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €-35.15 Million ≈ $-41.10 Million |
€-17.43 Million ≈ $-20.37 Million |
0.496x | -6.18% |
| 2024-12-31 | €-33.97 Million ≈ $-39.71 Million |
€-17.95 Million ≈ $-20.98 Million |
0.528x | -73.12% |
| 2023-12-31 | €-10.29 Million ≈ $-12.03 Million |
€-20.24 Million ≈ $-23.66 Million |
1.966x | -9.71% |
| 2022-12-31 | €-7.25 Million ≈ $-8.48 Million |
€-15.79 Million ≈ $-18.46 Million |
2.177x | +206.22% |
| 2021-12-31 | €4.94 Million ≈ $5.77 Million |
€-10.12 Million ≈ $-11.84 Million |
-2.050x | -526.68% |
| 2020-12-31 | €-11.36 Million ≈ $-13.28 Million |
€-5.46 Million ≈ $-6.38 Million |
0.480x | +114.03% |
| 2019-12-31 | €1.28 Million ≈ $1.50 Million |
€-4.39 Million ≈ $-5.13 Million |
-3.424x | -99.00% |
| 2018-12-31 | €9.09 Million ≈ $10.63 Million |
€-15.64 Million ≈ $-18.29 Million |
-1.721x | -209.88% |
| 2017-12-31 | €24.94 Million ≈ $29.15 Million |
€-13.85 Million ≈ $-16.19 Million |
-0.555x | -184.16% |
| 2016-12-31 | €38.74 Million ≈ $45.29 Million |
€-7.57 Million ≈ $-8.85 Million |
-0.195x | -36.23% |
| 2015-12-31 | €26.24 Million ≈ $30.68 Million |
€-3.76 Million ≈ $-4.40 Million |
-0.143x | +41.99% |
| 2014-12-31 | €13.78 Million ≈ $16.11 Million |
€-3.41 Million ≈ $-3.98 Million |
-0.247x | -- |
| 2013-12-31 | €0.00 ≈ $0.00 |
€-4.42 Million ≈ $-5.16 Million |
x | -- |
About Mediantechn
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnos… Read more